Stemedix

What Stemedix does

Stemedix is a privately held US regenerative medicine clinic operator headquartered in St. Petersburg, Florida, with a secondary site in Delray Beach. The company treats individual patients across neurodegenerative conditions (Parkinson's, Alzheimer's, ALS, MS, traumatic brain injury), orthopedic and musculoskeletal issues, autoimmune diseases (Rheumatoid Arthritis, Crohn's, Lupus, COPD, MS, Chronic Fatigue Syndrome), and wellness indications including hormone therapy, weight loss, and anti-aging. Its core clinical modality is autologous and allogeneic Mesenchymal Stem Cell (MSC) therapy, drawing MSCs from bone marrow aspirate, adipose tissue, and umbilical cord tissue (Wharton's Jelly), supplemented by exosome-based regenerative products with immune-modulatory and anti-inflammatory properties.

The company's technology platform is biological rather than software-based. The MSC sourcing matrix and exosome utilization constitute its principal technical differentiator, alongside physician-led personalization of treatment plans based on medical record review. The clinical offering is broadened by adjunctive services such as pain management, hormone replacement therapy, weight loss programs, the Health Blueprint precision health testing program, Botox, peptide therapy, vitamin infusions, Ozone IV therapy, and Prolozone therapy. The company also maintains an extended research collaboration with the University of South Florida and was recognized as the 2023 Top Regenerative Medicine Solution Provider.

Commercially, Stemedix operates a direct-to-patient, pay-as-you-go model with non-publicly disclosed per-treatment pricing. Patient acquisition is sales-led via a Care Coordinator intake process that funnels inquiries through medical record review, physician evaluation, and personalized treatment planning. Marketing is primarily content-driven across the company website, blog, patient testimonials, email newsletter, and organic social channels on LinkedIn and Instagram. The company is led by CEO Fred Palmer and operates with an 11-50 employee headcount from a single US state (Florida).

Name

Stemedix

Legal name

Stemedix, Inc.

Website

https://stemedix.com

Company type

Private

Operating status

Operating

Headcount range

11–50 employees

Short description

Stemedix is a Florida-based regenerative medicine clinic that provides stem cell therapy, pain management, hormone therapy, and wellness treatments to individual patients with neurodegenerative, orthopedic, autoimmune, and age-related conditions.

Ownership category

akta.pro rank

Product category

Regenerative Medicine Services

NAICS

Offices of Physical, Occupational and Speech Therapists, and Audiologists (62134), Research and Development in Biotechnology (except Nanobiotechnology) (541714)

SIC

Services-Offices & Clinics Of Doctors Of Medicine (8011)

akta.pro primary industry

Cell Therapy Clinical Services & Treatment Centers (apheresis, administration, monitoring) (HLAAABAJ)

akta.pro secondary industries

Stem Cell Therapies (MSC/iPSC/HSC-derived) (HLAAABAE), Stem Cell–Based Regenerative Therapies (HLAAAGAA), Cartilage, Bone & Musculoskeletal Regeneration (HLAAAGAH), Cell Therapy Developers (Allogeneic/Off-the-shelf) (HLAAABAB)

Keywords

• Regenerative medicine
• Stem cell therapy
• Pain management
• Hormone replacement therapy
• Wellness treatments

Headquarters

HQ city

Saint Petersburg

HQ country

United States

HQ region

North America

Offices2 records

Markets served

GTM type

B2C

Offering type

Services

Cost components

Personnel, Operations, Marketing or Sales, Technology or R&D, Infrastructure

Revenue model

1. Regenerative Medicine Treatments: Revenue generated from providing regenerative medicine treatments including stem cell therapy, pain management, hormone therapy, and related wellness services. Patients undergo consultation, evaluation, and customized treatment plans. The company provides treatments for various conditions including neurodegenerative diseases, orthopedic conditions, autoimmune conditions, and wellness treatments.

Pricing tiers

Go-to-market motion1 record

Distribution channels1 record

Marketing channels5 records

Core offering

Stemedix provides regenerative medicine treatments built on Mesenchymal Stem Cells (MSCs) sourced from bone marrow, adipose tissue, and umbilical cord tissue (Wharton's Jelly) to address neurodegenerative, orthopedic, autoimmune, and wellness conditions. The company combines these stem cell therapies with traditional pain management, hormone therapy, weight loss programs, and adjunct wellness services (Botox, peptides, ozone IV, vitamin infusions). Patient intake is managed through dedicated Care Coordinators who review medical history, evaluate candidacy, and coordinate customized treatment plans delivered by board-certified physicians at Stemedix's Florida facilities.

Product overview

Stemedix is a regenerative medicine company offering a comprehensive suite of treatment programs centered around stem cell therapy and biological regenerative approaches. The core offering is Regenerative Medicine using Mesenchymal Stem Cells (MSCs) sourced from bone marrow, adipose tissue, or umbilical cord tissue. The company provides treatment programs across multiple therapeutic areas: Neurodegenerative Diseases (Parkinson's, Alzheimer's, ALS, Multiple Sclerosis, Traumatic Brain Injury), Autoimmune Conditions (Rheumatoid Arthritis, Crohn's Disease, Lupus, COPD), Orthopedics, and general Wellness/Anti-aging. Supporting services include Pain Management, Hormone Therapy, Weight Loss Programs, Health Blueprint (precision health testing), Botox Injections, Peptides, Vitamins, Ozone IV Therapy, Prolozone Therapy, and Vitamin Infusions. The company operates care coordination services to support patients through evaluation, documentation review, and treatment planning, with facilities in St. Petersburg and Delray Beach, Florida.

Differentiator

Problem solved

Functional benefit

Products and services

• Pain Management Combines traditional pain management approaches with personalized regenerative medicine to deliver individualized pain management for patients with acute and chronic pain conditions. Available at Stemedix's Florida facilities.
• Regenerative Medicine Core treatment approach using Mesenchymal Stem Cells sourced from bone marrow, adipose tissue, or umbilical cord tissue (Wharton's Jelly) combined with exosome-based biological products to repair and regenerate damaged tissue across neurodegenerative, orthopedic, autoimmune, and wellness conditions.
• Personal Injury Care Specialized medical care and rehabilitation support for patients recovering from personal injuries, often sustained through motor vehicle accidents.
• Hormone Therapy for Men Hormone therapy program tailored for male patients to address hormonal imbalances and related wellness concerns.
• Hormone Therapy for Women Hormone therapy program tailored for female patients to address hormonal imbalances and related wellness concerns.
• Hormone Replacement Therapy Clinical hormone replacement therapy service for patients requiring structured hormone restoration protocols.
• Weight Loss Programs Comprehensive weight management programs delivered as part of Stemedix's broader wellness and health optimization offerings.
• Health Blueprint (Precision Health Program) Precision Health Program that includes comprehensive gut testing and produces personalized health recommendations from board-certified providers.
• Botox Injections Cosmetic and therapeutic Botox injection treatments offered as part of Stemedix's wellness service portfolio.
• Peptides Peptide-based therapeutic treatments offered as part of Stemedix's regenerative and wellness service portfolio.
• Vitamins Vitamin supplementation and nutrient-based therapies offered as part of Stemedix's wellness service portfolio.
• Ozone IV Therapy Intravenous ozone therapy delivered for therapeutic benefits as part of Stemedix's regenerative and wellness offerings.
• Prolozone Therapy Regenerative injection therapy that combines ozone with vitamins and minerals to support tissue repair and pain relief.
• Vitamin Infusions Intravenous vitamin infusion service designed to enhance nutrient absorption and support overall wellness.
• Stem Cell Therapy for Neurodegenerative Diseases Regenerative treatment program using mesenchymal stem cells to address neurodegenerative conditions including Alzheimer's disease, Parkinson's disease, ALS, and Multiple Sclerosis.
• Stem Cell Therapy for Orthopedics Regenerative treatment program using stem cell therapy for orthopedic conditions, joint pain, sports injuries, osteoarthritis, and musculoskeletal issues.
• Stem Cell Therapy for Autoimmune Diseases Regenerative treatment program using mesenchymal stem cells to modulate the immune system for autoimmune conditions including Rheumatoid Arthritis, COPD, Multiple Sclerosis, Crohn's Disease, Lupus, and Chronic Fatigue Syndrome.
• Stem Cell Wellness Programs Restorative stem cell wellness programs covering anti-aging, male wellness, hair loss, erectile dysfunction, facials, and female wellness to slow aging progression and rejuvenate cells.

Segments6 records

Ideal customer profiles5 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature3 records

Partnerships

One partnership is on record.

• University of South FloridacoreStrategic or Co-development PartnerStemedix and University of South Florida have an ongoing collaboration focused on regenerative medicine research and development. The collaboration has been extended, indicating a productive research partnership advancing stem cell therapy science.

Scale indicators1 record

Recent moves6 records

Expansion highlights5 records

Direct peers

• StemGenex: StemGenex is a California-based regenerative medicine clinic offering autologous stem cell therapy for neurological, autoimmune, and degenerative conditions. Overlapping directly with Stemedix on neurodegenerative and autoimmune indications and the patient-funded treatment model.
• Regenexx: Regenexx is one of the largest U.S. clinic networks offering autologous stem cell and platelet-rich plasma therapies for orthopedic and musculoskeletal conditions. It is the most direct competitor to Stemedix's orthopedic stem cell service line and shares the cash-pay clinic model.
• R3 Stem Cell: R3 Stem Cell runs a national network of regenerative medicine providers offering stem cell, exosome, and PRP therapies across multiple therapeutic areas. Comparable in offering breadth, clinic-partner model, and patient acquisition channels.
• Celltex Therapeutics: Celltex banks and administers autologous mesenchymal stem cells for therapeutic use across orthopedic, autoimmune, and neurological indications. Comparable technology platform and indication coverage; useful benchmark for cell banking plus treatment delivery.
• NSI Stem Cell: NSI operates a national clinic network providing regenerative medicine treatments using adipose- and bone-marrow-derived stem cells for orthopedic, autoimmune, and degenerative conditions. Highly comparable in service mix, patient acquisition model, and indication breadth.
• Personalized Stem Cells: Personalized Stem Cells focuses on FDA-compliant autologous adipose-derived stem cell therapies, primarily for orthopedic indications. Comparable in sourcing approach and clinic-led delivery, with a more orthopedic-centric portfolio.
• AgeRejuvenation: AgeRejuvenation runs multiple regenerative medicine clinics offering stem cell therapy, hormone replacement, and wellness treatments — a near-mirror of Stemedix's service mix and cash-pay, multi-vertical model.

Regional players

• BioGenix: BioGenix operates regenerative medicine clinics in the southeastern U.S., offering stem cell and PRP therapies for orthopedic, autoimmune, and wellness indications. Comparable in service scope and geography-adjacent to Stemedix's Florida footprint.

Emerging players

• Kimera Labs: Kimera Labs develops exosome and MSC-based regenerative products, intersecting with Stemedix's exosome feature offering. It is a younger, more product-focused player rather than a clinic operator, but competes for the same end patients via partner clinics.

Others

• VetStem Biopharma: VetStem provides autologous stem cell services for veterinary applications, sharing MSC sourcing and processing expertise with Stemedix but operating in a different end market. Useful as a technology/process peer rather than a direct competitor.

Market position

Strengths4 records

Weaknesses5 records

Competitive moat3 records

Key risks7 records

Key highlights6 records

Customer concentration

Revenue estimate

Valuation estimate

Number of profiles

Profiles1 record

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Stemedix